755 Prediction of recurrence probabilities after intravesical treatment in patients with non-muscle-invasive bladder cancer

2013 ◽  
Vol 12 (1) ◽  
pp. e755-e756
Author(s):  
R.J.M. Lammers ◽  
J.C.M. Hendriks ◽  
J. Palou ◽  
W.P.J. Witjes ◽  
J.A. Witjes
Keyword(s):  
Bladder Cancer ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Intravesical Treatment ◽  
Muscle Invasive

Carcinogenesis and Bacillus Calmette-Guérin (BCG) Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer under Tryptophan and Thymine Supplementation

2020 ◽  
pp. 1-8
Author(s):  
Marina V. Ossick ◽  
Heloisa B. Assalin ◽  
Isis G. A. Kiehl ◽  
Ana C. C. Salustiano ◽  
Guilherme Zweig Rocha ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Invasive Bladder Cancer ◽  
Bacillus Calmette Guerin ◽  
Muscle Invasive Bladder Cancer ◽  
Intravesical Treatment ◽  
Muscle Invasive

scholarly journals In vivo Evaluation of Mucoadhesive Nanoparticulate Docetaxel for Intravesical Treatment of Non–Muscle-Invasive Bladder Cancer

2011 ◽  
Vol 17 (9) ◽  
pp. 2788-2798 ◽  
Author(s):  
Clement Mugabe ◽  
Yoshiyuki Matsui ◽  
Alan I. So ◽  
Martin E. Gleave ◽  
Jennifer H. E. Baker ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
In Vivo Evaluation ◽  
Intravesical Treatment ◽  
Muscle Invasive

Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer

2012 ◽  
Vol 19 (11) ◽  
pp. 988-993 ◽  
Author(s):  
Andrew J Lightfoot ◽  
Henry M Rosevear ◽  
Kenneth G Nepple ◽  
Michael A O'Donnell
Keyword(s):  
Bladder Cancer ◽  
Invasive Bladder Cancer ◽  
High Grade ◽  
Muscle Invasive Bladder Cancer ◽  
Upper Tract ◽  
Intravesical Treatment ◽  
Muscle Invasive

Adjuvant intravesical treatment for non-muscle invasive bladder cancer: The importance of the strain and maintenance

2017 ◽  
Vol 41 (9) ◽  
pp. 590-595
Author(s):  
F. Guerrero-Ramos ◽  
A. Lara-Isla ◽  
J. Justo-Quintas ◽  
J.M. Duarte-Ojeda ◽  
F. de la Rosa-Kehrmann ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Intravesical Treatment ◽  
Muscle Invasive

A chemosensitivity test to individualize intravesical treatment for non-muscle-invasive bladder cancer

2009 ◽  
Vol 104 (2) ◽  
pp. 184-188 ◽  
Author(s):  
Paola Gazzaniga ◽  
Angela Gradilone ◽  
Ettore de Berardinis ◽  
Alessandro Sciarra ◽  
Cristiano Cristini ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Invasive Bladder Cancer ◽  
Chemosensitivity Test ◽  
Muscle Invasive Bladder Cancer ◽  
Intravesical Treatment ◽  
Muscle Invasive

Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer

2020 ◽  
Author(s):  
Luca Di Gianfrancesco ◽  
Mauro Ragonese ◽  
Giuseppe Palermo ◽  
Emilio Sacco ◽  
PierFrancesco Bassi ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
High Risk ◽  
Invasive Bladder Cancer ◽  
Second Line ◽  
Muscle Invasive Bladder Cancer ◽  
Intravesical Treatment ◽  
Muscle Invasive

scholarly journals Impact of Intravesical instillation of a Novel Biological Response Modifier (P-MAPA) on Progress of Non-Muscle Invasive Bladder Cancer Treatment in a rat model

2021 ◽  
Author(s):  
Wagner J. Fávaro ◽  
Eduardo A.R. Socca ◽  
Petra K. Böckelmann ◽  
Ianny B. Reis ◽  
Patrick V. Garcia ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Invasive Bladder Cancer ◽  
Wild Type ◽  
Protein Aggregate ◽  
Muscle Invasive Bladder Cancer ◽  
Protein Levels ◽  
Bax Protein ◽  
Intravesical Treatment ◽  
Wild Type P53 ◽  
Muscle Invasive

Abstract This work describes the effects of immunotherapy with Protein Aggregate Magnesium-Ammonium Phospholinoleate-Palmitoleate Anhydride (P-MAPA) in the treatment of non-muscle invasive bladder cancer (NMIBC) in an animal model. NMIBC was induced by treating female Fischer 344 rats with N-methyl-N-nitrosourea (MNU). After treatment with MNU, the rats were distributed into four experimental groups: Control (without MNU) group, MNU (cancer) group, MNU-BCG (Bacillus Calmette-Guerin) group and MNU-P-MAPA group. P-MAPA intravesical treatment was more effective in histopathological recovery from cancer state in relation to BCG treatment. Western blot assays showed an increase in the protein levels of c-Myc, COUP-TFII and wild-type p53 in P-MAPA-treated rats in relation to BCG-treated rats. In addition, rats treated with P-MAPA intravesical immunotherapy showed the highest BAX protein levels and the lowest proliferation/apoptotic ratio in relation to BCG-treated rats, pointing out a preponderance of apoptosis. P-MAPA intravesical treatment increased the wild-type p53 levels and enhanced c-Myc/COUP-TFII-induced apoptosis mediated by p53. These alterations were fundamental for histopathological recovery from cancer and for suppress abnormal cell proliferation. This action of P-MAPA on apoptotic pathways may represent a new strategy for treating NMIBC.

Sign in / Sign up

Export Citation Format

Share Document